ERANI ALBERT - 12 Nov 2024 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
10%+ Owner
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
12 Nov 2024
Net transactions value
-$23,450,443
Form type
4
Filing time
14 Nov 2024, 19:27:32 UTC
Previous filing
11 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Other $709,883 -224,668 -0.38% $3.16 58,782,466 12 Nov 2024 Direct F1, F2
transaction ORGO Class A Common Stock Other $1,865,272 -590,332 -1% $3.16 58,192,134 12 Nov 2024 Direct F1, F3
transaction ORGO Class A Common Stock Disposed to Issuer $928,952 -294,000 -0.51% $3.16 57,898,134 12 Nov 2024 Direct F1, F4
transaction ORGO Class A Common Stock Disposed to Issuer $11,886,504 -3,761,909 -6.5% $3.16 54,136,225 12 Nov 2024 Direct F1, F5
transaction ORGO Class A Common Stock Disposed to Issuer $8,059,832 -2,550,822 -4.7% $3.16 51,585,403 12 Nov 2024 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024.
F2 Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares.
F3 Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein.
F4 Reflects the total number of securities held by the Group. Only Alan A. Ades has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the third line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares.
F5 Reflects the total number of securities held by the Group. Only the Alan Ades 2014 GRAT has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the fourth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Alan A. Ades, who is the Trustee of the Alan Ades 2014 GRAT, and who disclaims ownership of the shares held by the Alan Ades 2014 GRAT, except to the extent of his pecuniary interest therein.
F6 Reflects the total number of securities held by the Group. Only Glenn H. Nussdorf has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the fifth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares.

Remarks:

Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom and certain of their respective affiliates, including Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust, Alan Ades as Trustee of the Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 and RED Holdings, LLC, referred to collectively as the "Group", are parties to a Controlling Stockholders' Agreement dated December 10, 2018 with Organogenesis Holdings Inc. (the "Stockholders' Agreement"). The Stockholders' Agreement, among other things, provides for nomination rights of the Group with respect to four directors of the Issuer. As a result of the Stockholders' Agreement, the reporting persons may be deemed to be members of a group holding over 10% of the outstanding shares of common stock of the issuer for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. This is Form 4 No. 1 of 2 filed for the Group.